Vertex currently operates at the forefront of rare disease scientific innovation and has successfully developed and commercialized multiple breakthrough medicines for Cystic Fibrosis (CF), Sickle Cell Disease, Transfusion-Dependent Beta Thalassemia and Acute Pain. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases including programs in Diabetic Peripheral Neuropathy, Type 1 Diabetes, IgA Nephropathy (IgAN), APOL-1 Mediated Kidney Disease, and Muscular Dystrophy, among others. The Associate Director, Channel Distribution Strategy will be responsible for leading the evolution of the distribution strategy for the Cystic Fibrosis (CF) portfolio as well as preparing and planning for CF pipeline assets. This individual will lead strategic planning considering regulations and policies, program sustainability, strategic alliances, patient and customer access, data, class of trade and setting of care. They will inform distribution service agreement design to support maximum access and distribution efficiency. They will leverage access and reimbursement expertise and considerations across a variety of drug types spanning cell and gene therapies. The ideal candidate combines pharmaceutical channel distribution expertise with strategic acumen, cross-functional collaboration and the ability to navigate complex trade and emerging therapy models.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level